-Alnylam Announces U.S. Food and Drug Administration Approval of OXLUMO, the First and Only Treatment Approved for Primary Hyperoxaluria Type 1

Press/Media

Period25 Nov 2020

Media coverage

1

Media coverage

  • Title-Alnylam Announces U.S. Food and Drug Administration Approval of OXLUMO, the First and Only Treatment Approved for Primary Hyperoxaluria Type 1
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date25/11/20
    PersonsJeffrey Saland
View all 1
View less